Search

everythinglearnresearchcommunity

for

Search:↓

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

Ritlecitinib is safe and may effectively treat alopecia areata.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Baricitinib works better in adolescents than adults for treating severe alopecia areata.

A standard protocol for alopecia areata clinical trials was created to improve consistency and encourage more research.

Targeting the AhR pathway may help treat alopecia areata.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Fludalanine failed as an effective oral antibiotic despite efforts.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

These gene variations are not linked to alopecia areata in Egyptians.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

There's no link between low iron levels and the hair loss condition, alopecia areata.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Topical tofacitinib is effective and safe for treating alopecia areata.

Ritlecitinib is effective long-term for treating alopecia areata in teens.

Tofacitinib successfully treated hair loss in a Crohn's disease patient who previously used adalimumab.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Tofacitinib effectively and safely promotes hair regrowth in alopecia patients.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Familial frontal fibrosing alopecia is rare, mostly affects women, and often occurs between sisters or mother-daughter pairs.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.